EVENTS

May 3, 2023

Annual Meeting of the Association for Cancer Immunotherapy (CIMT) 2023

Focus on the mechanism of action of anti-tumor activity for lead asset YB-200

May 3, 2023

LSX World Congress 2023 in London

Dr. Schiemann presents at the Biotech Forum on innovative treatments using new classes of antibodies

Apr 24, 2023

Swiss Biotech Day 2023

Ymmunobio team represents Ymmunobio for Swiss Biotech Day 2023

Nov 11, 2022

37th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

Ymmunobio Presented Pre-Clinical Data on the Anti-Cancer Activity of Lead Asset YB-200

Oct 25, 2022

BIO-Europe Start-up Spotlight 2022

Ymmunobio at the "Gateway to the Global Biopharma Community"